• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4例疑似左乙拉西坦诱发的无症状性横纹肌溶解症

Four Cases of Suspected Levetiracetam-Induced Asymptomatic Rhabdomyolysis.

作者信息

Saito Satoshi, Iijima Mutsumi, Ikeguchi Ryotaro, Ishizuka Kentaro, Kitagawa Kazuo

机构信息

Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, JPN.

出版信息

Cureus. 2023 Jul 10;15(7):e41666. doi: 10.7759/cureus.41666. eCollection 2023 Jul.

DOI:10.7759/cureus.41666
PMID:37575737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10412751/
Abstract

Rhabdomyolysis is a known side effect of levetiracetam. In general, a patient with rhabdomyolysis complains of muscle pain and swelling. Herein, we report four cases of asymptomatic levetiracetam-induced rhabdomyolysis. In all the four cases, the seizures resolved after more than five days. The patients received continuous fluid replacement from the time they were admitted to our hospital. However, serum creatine kinase (CK) levels continued to rise without symptoms consistent with rhabdomyolysis. The serum CK level improved rapidly when levetiracetam was replaced with lacosamide. Because levetiracetam occasionally causes asymptomatic rhabdomyolysis, routine blood tests should be performed after its initiation.

摘要

横纹肌溶解是左乙拉西坦已知的副作用。一般来说,患有横纹肌溶解的患者会抱怨肌肉疼痛和肿胀。在此,我们报告4例无症状的左乙拉西坦诱发的横纹肌溶解病例。在所有这4例病例中,癫痫发作在5天多后缓解。患者从入院时起就接受持续的液体补充。然而,血清肌酸激酶(CK)水平持续升高,且无与横纹肌溶解相符的症状。当用拉科酰胺替代左乙拉西坦后,血清CK水平迅速改善。由于左乙拉西坦偶尔会导致无症状性横纹肌溶解,因此在开始使用后应进行常规血液检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9735/10412751/5b5a4e5f865f/cureus-0015-00000041666-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9735/10412751/e757d59a259a/cureus-0015-00000041666-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9735/10412751/0d744e9334e0/cureus-0015-00000041666-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9735/10412751/2488d1d860bc/cureus-0015-00000041666-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9735/10412751/5b5a4e5f865f/cureus-0015-00000041666-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9735/10412751/e757d59a259a/cureus-0015-00000041666-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9735/10412751/0d744e9334e0/cureus-0015-00000041666-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9735/10412751/2488d1d860bc/cureus-0015-00000041666-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9735/10412751/5b5a4e5f865f/cureus-0015-00000041666-i04.jpg

相似文献

1
Four Cases of Suspected Levetiracetam-Induced Asymptomatic Rhabdomyolysis.4例疑似左乙拉西坦诱发的无症状性横纹肌溶解症
Cureus. 2023 Jul 10;15(7):e41666. doi: 10.7759/cureus.41666. eCollection 2023 Jul.
2
Levetiracetam-Induced Rhabdomyolysis Following Medication Re-Initiation.重新开始用药后左乙拉西坦诱发的横纹肌溶解症
Cureus. 2022 Oct 7;14(10):e30042. doi: 10.7759/cureus.30042. eCollection 2022 Oct.
3
Creatine Kinase Surge: Levetiracetam-Induced Rhabdomyolysis.肌酸激酶激增:左乙拉西坦诱发的横纹肌溶解症。
Cureus. 2024 Aug 12;16(8):e66715. doi: 10.7759/cureus.66715. eCollection 2024 Aug.
4
Suspected Levetiracetam-Induced Rhabdomyolysis: A Case Report and Literature Review.怀疑左乙拉西坦诱发横纹肌溶解症:一例报告及文献综述
Am J Case Rep. 2020 Oct 28;21:e926064. doi: 10.12659/AJCR.926064.
5
Rhabdomyolysis: a rare adverse effect of levetiracetam.横纹肌溶解症:左乙拉西坦一种罕见的不良反应。
BMJ Case Rep. 2019 Aug 26;12(8):e230851. doi: 10.1136/bcr-2019-230851.
6
Levetiracetam-Induced Rhabdomyolysis Reversed by Discontinuation: A Case Report.停用左乙拉西坦后逆转的横纹肌溶解症:一例报告
Cureus. 2023 Nov 17;15(11):e48955. doi: 10.7759/cureus.48955. eCollection 2023 Nov.
7
A case of rhabdomyolysis in which levetiracetam was suspected as the cause.一例怀疑左乙拉西坦为病因的横纹肌溶解症病例。
Epilepsy Behav Case Rep. 2014 Sep 16;2:152-5. doi: 10.1016/j.ebcr.2014.08.001. eCollection 2014.
8
Suspected Levetiracetam-Induced Acute Rhabdomyolysis in a Patient With Retinoblastoma: A Case Report and Literature Review.视网膜母细胞瘤患者疑似左乙拉西坦诱发的急性横纹肌溶解症:一例报告及文献综述
Cureus. 2022 May 21;14(5):e25183. doi: 10.7759/cureus.25183. eCollection 2022 May.
9
Cabozantinib-induced serum creatine kinase elevation and rhabdomyolysis: a retrospective case series.卡博替尼引起的血清肌酸激酶升高和横纹肌溶解:回顾性病例系列。
Cancer Chemother Pharmacol. 2023 Sep;92(3):235-240. doi: 10.1007/s00280-023-04557-0. Epub 2023 Jun 28.
10
Rhabdomyolysis: A Rare Adverse Effect of Levetiracetam.横纹肌溶解症:左乙拉西坦一种罕见的不良反应。
Cureus. 2018 May 29;10(5):e2705. doi: 10.7759/cureus.2705.

引用本文的文献

1
Two Cases of Levetiracetam-Induced Rhabdomyolysis With Low Levetiracetam Blood Concentrations.两例左乙拉西坦血药浓度低时左乙拉西坦诱导的横纹肌溶解症
Cureus. 2025 Mar 20;17(3):e80877. doi: 10.7759/cureus.80877. eCollection 2025 Mar.
2
Weighing the Risk of Seizure Control: A Case of Levetiracetam-Induced Rhabdomyolysis.权衡癫痫控制的风险:一例左乙拉西坦诱发的横纹肌溶解症
Cureus. 2024 Nov 20;16(11):e74111. doi: 10.7759/cureus.74111. eCollection 2024 Nov.
3
Rhabdomyolysis Induced by Levetiracetam: A Case Report in Kuwait.左乙拉西坦诱发的横纹肌溶解症:科威特的一例病例报告

本文引用的文献

1
Suspected Levetiracetam-Induced Rhabdomyolysis: A Case Report and Literature Review.怀疑左乙拉西坦诱发横纹肌溶解症:一例报告及文献综述
Am J Case Rep. 2020 Oct 28;21:e926064. doi: 10.12659/AJCR.926064.
2
Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).横纹肌溶解症与抗生素的关联:FDA 不良事件报告系统(FAERS)的药物警戒研究。
Int J Med Sci. 2019 Oct 15;16(11):1504-1509. doi: 10.7150/ijms.38605. eCollection 2019.
3
Rhabdomyolysis: A Rare Adverse Effect of Levetiracetam.
Case Rep Neurol Med. 2024 Sep 21;2024:1234738. doi: 10.1155/2024/1234738. eCollection 2024.
4
Levetiracetam-Induced Rhabdomyolysis Reversed by Discontinuation: A Case Report.停用左乙拉西坦后逆转的横纹肌溶解症:一例报告
Cureus. 2023 Nov 17;15(11):e48955. doi: 10.7759/cureus.48955. eCollection 2023 Nov.
横纹肌溶解症:左乙拉西坦一种罕见的不良反应。
Cureus. 2018 May 29;10(5):e2705. doi: 10.7759/cureus.2705.
4
Levetiracetam-induced rhabdomyolysis: the first Italian case.左乙拉西坦诱发的横纹肌溶解症:首例意大利病例。
Neurol Sci. 2018 Sep;39(9):1629-1630. doi: 10.1007/s10072-018-3421-3. Epub 2018 Apr 26.
5
A case of rhabdomyolysis in which levetiracetam was suspected as the cause.一例怀疑左乙拉西坦为病因的横纹肌溶解症病例。
Epilepsy Behav Case Rep. 2014 Sep 16;2:152-5. doi: 10.1016/j.ebcr.2014.08.001. eCollection 2014.
6
Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.左乙拉西坦添加治疗耐药性局灶性癫痫:Cochrane系统评价的更新版
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD001901. doi: 10.1002/14651858.CD001901.pub2.
7
Retrograde influence of muscle fibers on their innervation revealed by a novel marker for slow motoneurons.慢运动神经元新标记物揭示肌肉纤维对其神经支配的逆行影响。
Development. 2010 Oct;137(20):3489-99. doi: 10.1242/dev.053348. Epub 2010 Sep 15.
8
The syndrome of rhabdomyolysis: complications and treatment.横纹肌溶解综合征:并发症与治疗
Eur J Intern Med. 2008 Dec;19(8):568-74. doi: 10.1016/j.ejim.2007.06.037. Epub 2008 Apr 28.
9
Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures.左乙拉西坦用于治疗伴有肌阵挛发作的特发性全身性癫痫。
Neurology. 2008 Feb 19;70(8):607-16. doi: 10.1212/01.wnl.0000297512.18364.40.
10
Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy.左乙拉西坦治疗特发性全身性癫痫的安慰剂对照研究。
Neurology. 2007 Oct 30;69(18):1751-60. doi: 10.1212/01.wnl.0000268699.34614.d3. Epub 2007 Jul 11.